Bone Mineral Density in Neurofibromatosis Type 1: A Systematic Review and Meta-Analysis

Area of Science:

• Endocrinology and Metabolism
• Genetics and Genetic Diseases
• Orthopedics

Background:

• Neurofibromatosis type 1 (NF1) is a genetic disorder associated with various complications, including potential effects on bone health.
• Bone mineral density (BMD) assessment is crucial for evaluating skeletal health and fracture risk.
• Understanding BMD variations in NF1 patients is essential for clinical management.

Approach:

• A systematic review and meta-analysis was conducted to synthesize existing data on BMD in NF1 patients.
• Studies were identified through comprehensive searches of Medline and EMBASE databases.
• Data from 19 eligible studies, including adult and pediatric populations, were meta-analyzed using the generic inverse variance method.

Key Points:

• Meta-analysis revealed significantly negative mean Z-scores for total body, lumbar spine, femoral neck, and total hip BMD in NF1 patients.
• Subgroup analysis in pediatric patients (<18 years) also showed negative Z-scores for lumbar spine and femoral neck BMD.
• Despite statistically significant reductions, the observed low BMD Z-scores may not reach clinical significance.

Conclusions:

• Patients with NF1 exhibit lower bone mineral density compared to controls.
• The degree of BMD reduction in NF1 patients may not warrant routine early screening in children and young adults.
• Further research may be needed to determine the clinical implications and optimal monitoring strategies for bone health in NF1.